Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06880341 · ClinicalTrials.gov registry record
Managing Transient Neurologic Episodes in Surgery for Moyamoya Disease
A clinical trial of Moya Moya Disease, sponsored by Stanford University.
- Recruiting
- Registry status
- 88
- Enrollment target
- 1
- Study location
NCT06880341: Recruiting study of Moya Moya Disease, sponsored by Stanford University.
NCT06880341 is a study of Moya Moya Disease that is actively recruiting participants, run by Stanford University. The registered enrollment target is 88 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06880341, a study of Moya Moya Disease, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to study the incidence of post-operative Transient Neurologic Events (TNEs) within 30 days postoperatively, as assessed by clinical neurological scales, binned by week. Collect data on all interventions and assessments performed during the recovery post surgery up to 30 days, to understand what factors might cause Transient Neurologic Events (TNEs) and determine how these can be reduced in Moyamoya subjects post surgery.
Primary Outcome
Number of Incidence of post-operative Transient Neurologic Events (TNEs) within 30 days postoperatively, as assessed by clinical neurological scales (e.g., NIH Stroke Scale, Modified Rankin Scale), binned by week.
Conditions Studied
Interventions
- OTHER Standard of Care
Study Locations (1)
California
- Stanford University Hospital - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2025-05-21 |
| Est. Completion | 2027-03-31 |
What NCT06880341 shows while recruiting
NCT06880341 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 88 participants, a relatively small participant target.
The record links to 1 condition, with Moya Moya Disease appearing as the primary indexed condition, and to 1 intervention - of which Standard of Care is the first listed.
NCT06880341 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06880341 about?
NCT06880341 is a clinical study titled "Managing Transient Neurologic Episodes in Surgery for Moyamoya Disease". The goal of this study is to study the incidence of post-operative Transient Neurologic Events (TNEs) within 30 days postoperatively, as assessed by clinical neurological scales, binned by week. Collect data on all interventions and assessments performed during the recovery post surgery up to 30 day...
What is the current status of trial NCT06880341?
This trial is currently recruiting. The enrollment target is 88 participants. The study started on 2025-05-21. Estimated completion is 2027-03-31.
What conditions does trial NCT06880341 study?
This clinical trial studies the following conditions: Moya Moya Disease.
What interventions are being tested in trial NCT06880341?
The interventions under investigation include: Standard of Care (OTHER).
Who is sponsoring clinical trial NCT06880341?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06880341 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Moya Moya Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI